Qube Research & Technologies (QRT)
MBRX icon

Qube Research & Technologies (QRT)’s Moleculin Biotech MBRX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3
Closed -$105K – 2211
2020
Q4 		$105K Sell
3
-5
-63% -$177K ﹤0.01% 1640
2020
Q3 		$293K Buy
8
+7
+700% +$298K ﹤0.01% 1255
2020
Q2 		$62K Buy
+1
New +$47.4K ﹤0.01% 1573

Other funds holding MBRX

Sio Capital Management
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return
Susquehanna Fundamental Investments
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $5.32B AUM 30.24% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Two Sigma Securities
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MBRX Position: Q1 2021 in Review

Qube Research & Technologies (QRT) sold out of Moleculin Biotech (MBRX) in Q1 2021, closing a stake of 3 shares — an estimated $105K sold.

Qube Research & Technologies (QRT) first reported a position in MBRX in Q2 2020 and held it in 3 quarters. The position peaked at $293K in Q3 2020. 18 funds tracked by Wall St. Rank hold MBRX as of Q1 2021.

  • Qube Research & Technologies (QRT) reported no remaining Moleculin Biotech position as of Q1 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 3 Moleculin Biotech shares in Q1 2021, an estimated $105K.
  • Qube Research & Technologies (QRT) first reported a position in Moleculin Biotech in Q2 2020 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Moleculin Biotech position peaked at $293K in Q3 2020.
  • 18 funds tracked by Wall St. Rank held Moleculin Biotech as of Q1 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.